2011
DOI: 10.4061/2011/835750
|View full text |Cite
|
Sign up to set email alerts
|

Saddle Pulmonary Embolism in a Cancer Patient with Thrombocytopenia: A Treatment Dilemma

Abstract: The association between cancer and venous thromboembolism (VTE) is well established. Saddle pulmonary embolism is not uncommon in hospitalized cancer patients and confers a higher mortality. We report a case of saddle pulmonary embolism in a cancer patient with thrombocytopenia, discuss the bleeding risks, complexity of managing such patients and review current guidelines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…As mentioned before, risk of VTE is increased in COVID-19 infection particularly in pregnant women, therefore initiation of anticoagulants was recommended in this population [6]. D-dimer level of the patient increased to 1290 µg/L, the level is above of D-dimer threshold (1250 µg/L) in third-trimester pregnancy [10]. The existence of thrombocytopenia and emergency cesarean section should be undergone, anticoagulant treatment was decided to be postponed and planned to be administered after thrombocyte level increases.…”
Section: Discussionmentioning
confidence: 99%
“…As mentioned before, risk of VTE is increased in COVID-19 infection particularly in pregnant women, therefore initiation of anticoagulants was recommended in this population [6]. D-dimer level of the patient increased to 1290 µg/L, the level is above of D-dimer threshold (1250 µg/L) in third-trimester pregnancy [10]. The existence of thrombocytopenia and emergency cesarean section should be undergone, anticoagulant treatment was decided to be postponed and planned to be administered after thrombocyte level increases.…”
Section: Discussionmentioning
confidence: 99%
“…There is no evidence on the use of thrombolysis in patients with thrombocytopenia [13]. Cases are reported in the literature where the use of endoluminal thrombolysis in patients with heparin-induced purpura thrombocytopenia did not increase the risk of bleeding [14, 15].…”
Section: Discussionmentioning
confidence: 99%